Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation

Published:2024-09 Issue: Volume:22 Page:200297
ISSN:2772-4875
Container-title:International Journal of Cardiology Cardiovascular Risk and Prevention
language:en
Short-container-title:International Journal of Cardiology Cardiovascular Risk and Prevention

Author:

Surma Stanisław^ORCID,Zembala Michał O.,Okopień Bogusław,Banach Maciej

Publisher

Elsevier BV

Reference50 articles.

1. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society;Kronenberg;Atherosclerosis,2023

2. Recommendations of the experts of the polish cardiac society (PTK) and the polish lipid society (PTL) on the diagnosis and management of elevated lipoprotein (a) levels;Sosnowska;Arch. Med. Sci.,2024

3. The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?;Banach;Arch. Med. Sci.,2023

4. Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B-based genetic analysis;Björnson;J. Am. Coll. Cardiol.,2024

5. Lipoprotein(a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease;Berman;J. Am. Coll. Cardiol.,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP